Samumed Sm04554 Results Normalized To Baseline

MrV88

Senior Member
My Regimen
Reaction score
1,242
Maybe we get some results at one of these conferences:
 

poopfeast420

Established Member
My Regimen
Reaction score
183
They said they would present their results at a congress, if it was such a failure as the retarded haters here claim they wouldn't take the time and effort to do this but just silently publish it without making any noise.
Their CFO said they would present results mid May. Two months later all we've seen is their CEO and general counsel leave the company ...
 

pegasus2

Senior Member
My Regimen
Reaction score
5,022
You forget the world was in peak corona times the first half of the year, a delay was to be expected and especially when they want to present their results at a congress where many people visit. This is also in line with their phase II results, which they also presented at a dermatology congress in Turkey.

And a change in management, etc is nothing special considering they're preparing for IPO. Also the latest real news was another successful clinical trial for osteoarthritis.
I'm going to make a fortune shorting their ipo
 

JaneyElizabeth

Banned
My Regimen
Reaction score
2,023
The only baldness drug to reach a phase 3 clinical trial in 25 years and it turned out to be nothing. Son of a f*****g b**ch.
I am sorry that they put you guys through this unduly especially since treating hair loss is hard for everybody, male, female, some times youth and trannies even. Your skeptical nature seems to protect you though, Ralph.
 

JaneyElizabeth

Banned
My Regimen
Reaction score
2,023
Anyone able to explain succinctly what the premise of the treatment was supposed to be or do? Yeah, I could go research it but eh, you guys are saying it's finished for sure.
 

coolio

Experienced Member
My Regimen
Reaction score
474
We all knew this was coming. The company has been acting shady AF for months. Their hair claims were part of a larger pattern of bullshitting.
 

hmmmmmmmm

Established Member
My Regimen
Reaction score
103
"the fda requires that all trials that are registered with them (ie their phase 3 trial) be published, so we will see the data eventually"

Anyone know if this is true?

Found this; https://www.fda.gov/news-events/pre...l-trial-results-information-clinicaltrialsgov
It's technically true, but in reality the majority of trials (especially for failed ones) are never published. Plus the FDA has no meaningful enforcement arm, and simply encourages "voluntary" compliance:

Those sponsors, typically either the institution conducting a trial or its funder, must deposit results and other data within 1 year of completing a trial. But of 184 sponsor organizations with at least five trials due as of 25 September 2019, 30 companies, universities, or medical centers never met a single deadline. As of that date, those habitual violators had failed to report any results for 67% of their trials and averaged 268 days late for those and all trials that missed their deadlines

But I think they'll publish it eventually, no real downside to doing so because everyone is already assuming worst case
 

pegasus2

Senior Member
My Regimen
Reaction score
5,022
Check comments https://www.folliclethought.com/kintors-kx-826-pyrilutamide-meets-goal-in-phase-2-trial/#comments

Some people messaged Biosplice, their response:

"Thank you for your interest in Biosplice’s investigational drug, SM04554.
Biosplice is not pursuing further independent development of SM04554 for androgenetic alopecia and is evaluating global out-licensing opportunities for further development and commercialization of this program"

Interesting, so it could still get on the market.
This is a boilerplate response in biotech when you have a bad drug but you still want people to invest in your company. It's never coming out
 

Throwaway94

Experienced Member
My Regimen
Reaction score
614
Check comments https://www.folliclethought.com/kintors-kx-826-pyrilutamide-meets-goal-in-phase-2-trial/#comments

Some people messaged Biosplice, their response:

"Thank you for your interest in Biosplice’s investigational drug, SM04554.
Biosplice is not pursuing further independent development of SM04554 for androgenetic alopecia and is evaluating global out-licensing opportunities for further development and commercialization of this program"

Interesting, so it could still get on the market.
Are you ok? Remember it's fine to reach out and ask for help when you get such devastating news
 
Top